论文信息 - PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. - 字舞流文

PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma.

D. Esseltine | J. Stec | J. Cavenagh | D. Schenkein | R. Popat | S. Agrawal | H. Oakervee | M. Drake | T. Morris | Patricia Smith | Nikki Curry